Last updated at 01 Jul 2024 09:26 AM
Director
DIN: 01961003
Basavaraju Murali Krishna is currently associated with 2 companies as Director. They serve as a Director at SANGFROID PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01961003.Basavaraju Murali Krishna has previously been associated with 2 companies in roles such as Director.Basavaraju Murali Krishna is currently involved in 1 different role. Their most recent position is with GREESHA LABORATORIES PRIVATE LIMITED as a Director. The first company Basavaraju Murali Krishna was appointed to as a director was SANGFROID PHARMA PRIVATE LIMITED. Basavaraju Murali Krishna is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Basavaraju Murali Krishna is currently associated with 2 companies as Director. They serve as a Director at SANGFROID PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01961003.Basavaraju Murali Krishna has previously been associated with 2 companies in roles such as Director.Basavaraju Murali Krishna is currently involved in 1 different role. Their most recent position is with GREESHA LABORATORIES PRIVATE LIMITED as a Director. The first company Basavaraju Murali Krishna was appointed to as a director was SANGFROID PHARMA PRIVATE LIMITED. Basavaraju Murali Krishna is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
5 Years 2y 6m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SANGFROID PHARMA PRIVATE LIMITED | Director | 10-Oct-2012 |
| GREESHA LABORATORIES PRIVATE LIMITED | Director | 03-Aug-2020 |